Advertisement

Bupivacaine Injection

[24 October 2014]

Products Affected - Description

Bupivacaine 0.25%
Bupivacaine 0.25% injection, Hospira
20 mL glass ampule, sterile pack (NDC 00409-4272-01)
 
0.25% Sensorcaine, Fresenius Kabi
30 mL vial, preservative-free (NDC 63323-0464-37)
50 mL vial, multi-dose (NDC 63323-0465-57)
 
0.5% Bupivacaine
0.5% Bupivacaine injection, AuroMedics
30 mL vial, preservative-free (NDC 55150-0170-30)
 
0.5% Sensorcaine, Fresenius Kabi
50 mL vial, multi-dose (NDC 63323-0467-57)
 
0.75% Bupivacaine
0.75% Sensorcaine, Fresenius Kabi
10 mL vial, preservative-free (NDC 63323-0472-17)

Reason for the Shortage

  • Fresenius Kabi (formerly APP) has Sensorcaine on shortage due to increased demand for the product.
  • Hospira has Marcaine and bupivacaine on shortage due to manufacturing delays.
  • AuroMedics introduced bupivacaine injection in February 2014.

Available Products

0.25% Bupivacaine
0.25% Bupivacaine injection, AuroMedics

10 mL vial, preservative-free (NDC 55150-0167-10)
30 mL vial, preservative-free (NDC 55150-0168-30)
 
0.25% Sensorcaine, Fresenius Kabi
10 mL vial, preservative-free (NDC 63323-0464-17)
30 mL vial, preservative-free, sterile pack (NDC 63323-0464-31)

0.25% Bupivacaine injection, Hospira
10 mL vial, preservative-free (NDC 00409-1159-01)
30 mL glass ampule (NDC 00409-1158-01)
30 mL vial, preservative-free (NDC 00409-1159-02)
50 mL vial, multi-dose (NDC 00409-1160-01)  
 
0.25% Marcaine injection, Hospira
10 mL vial, preservative-free (NDC 00409-1559-10)
30 mL vial, preservative-free (NDC 00409-1559-30)
50 mL vial, multi-dose (NDC 00409-1587-50)
 
0.5% Bupivacaine
0.5% Bupivacaine injection, AuroMedics
10 mL vial, preservative-free (NDC 55150-0169-10)
30 mL vial, preservative-free (NDC 55150-0170-30)

0.5% Sensorcaine, Fresenius Kabi
10 mL vial, preservative-free (NDC 63323- 0466-17)
30 mL vial, preservative-free (NDC 63323- 0466-37)
30 mL vial, preservative-free, sterile pack (NDC 63323-0466-31)

0.5% Bupivacaine, Hospira
10 mL vial, preservative-free (NDC 00409-1162-01)
30 mL vial, preservative-free (NDC 00409-1162-02)
30 mL glass ampule (NDC 00409-1161-01)
50 mL vial, multi-dose (NDC 00409- 1163-01)
20 mL glass ampule, sterile pack (NDC 00409-4273-01)
 
0.5% Marcaine, Hospira
10 mL vial, preservative-free (NDC 00409-1560-10)
30 mL vial, preservative-free (NDC 00409-1560-29)
50 mL vial, multi-dose (NDC 00409-1610-50)
 
0.75% Bupivacaine
0.75% Bupivacaine injection, AuroMedics

10 mL vial, preservative-free (NDC 55150-0171-10)
30 mL vial, preservative-free (NDC 55150-0172-30)
 
0.75% Sensorcaine, Fresenius Kabi
30 mL vial, preservative-free (NDC 63323-0472-37)
 
0.75% Bupivacaine, Hospira
10 mL vial, preservative-free (NDC 00409-1165-01)
30 mL vial, preservative-free (NDC 00409-1165-02)
 
0.75% Marcaine, Hospira
30 mL vial, preservative-free (NDC 00409-1582-29)
10 mL vial, preservative-free (NDC 00409-1582-10)

Estimated Resupply Dates

Bupivacaine 0.25%
  • Hospira has 0.25% bupivacaine 20 mL ampule sterile packs on back order and the company cannot estimate a release date.
  • Fresenius Kabi has 0.25% Sensorcaine 50 mL vials on back order and the company estimates a release date in early-November 2014. The 30 mL preservative-free vials are on back order and the company estimates a release date of late-November 2014.

0.5% Bupivacaine

  • Auromedics has 0.5% bupivacaine 30 mL preservative-free vials on back order and the company estimates a release date in late-October 2014.
  • Fresenius Kabi has 0.5% Sensorcaine 50 mL vials on back order and the company cannot estimate a release date.

0.75% Bupivacaine

  • Fresenius Kabi has 0.75% Sensorcaine 10 mL preservative-free vials on back order and the company estimates a release date in late-October 2014.

Related Shortages

Updated

October 24, 2014; October 14, 2014; September 19, 2014; September 3, 2014; August 8, 2014; July 16, 2014; July 3, 2014; June 26, 2014; June 19, 2014; May 21, 2014; April 25, 2014; April 7, 2014; March 17, 2014; February 27, 2014; January 6, 2014; December 3, 2013; November 11, 2013; November 7, 2013; October 30, 2013; September 5, 2013; August 6, 2013; July 12, 2013; June 13, 2013; May 24, 2013; April 4, 2013; March 13, 2013; February 7, 2013; January 17, 2013; December 12, 2012; November 9, 2012; October 22, 2012; September 19, 2012; August 22, 2012; July 10, 2012; June 18, 2012; May 17, 2012; April 16, 2012; March 27, 2012; March 7, 2012; February 22, 2012; February 8, 2012; January 25, 2012; January 5, 2012; December 21, 2011; December 7, 2011; November 21, 2011; November 16, 2011; University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement